Merrill MH, Dahi PB, Redd RA, McDonough M, et al. A Phase 2 Study of pembrolizumab after Autologous Stem Cell Transplantation in Patients with T-Cell non-Hodgkin Lymphoma. Blood 2023 Jun 15:blood.2023020244. doi: 10.1182/blood.2023020244.
PMID: 37319432